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The cystic fibrosis (CF) transmembrane regulator
(CFTR) is a cyclic AMP-dependent Cl2 channel that is
defective in CF cells. It has been hypothesized that
CFTR exhibits an ATP release function that controls the
airway surface ATP concentrations. In airway epithelial
cells, CFTR-independent Ca21-activated Cl2 conduct-
ance is regulated by the P2Y2 receptor. Thus, ATP may
function as an autocrine signaling factor promoting Cl2
secretion in normal but not CF epithelia if ATP release
is defective. We have tested for CFTR-dependent ATP
release using four independent detection systems. First,
a luciferase assay detected no differences in ATP con-
centrations in the medium from control versus cyclic
AMP-stimulated primary normal human nasal epithelial
(HNE) cells. A marked accumulation of extracellular
ATP resulted from mechanical stimulation effected by a
medium displacement. Second, high pressure liquid
chromatography analysis of 3H-labeled species released
from [3H]adenine-loaded HNE cells revealed no differ-
ences between basal and cyclic AMP-stimulated cells.
Mechanical stimulation of HNE cells again resulted in
enhanced accumulation of extracellular [3H]ATP and
[3H]ADP. Third, when measuring ATP concentrations
via nucleoside diphosphokinase-catalyzed phosphoryla-
tion of [a-33P]dADP, equivalent formation of [33P]dATP
was observed in the media of control and cyclic AMP-
stimulated HNE cells and nasal epithelial cells from
wild-type and CF mice. Mechanically stimulated
[33P]dATP formation was similar in both cell types.
Fourth, 1321N1 cells stably expressing the human P2Y2
receptor were used as a reporter system for detection of
ATP via P2Y2 receptor-promoted formation of [
3H]inosi-
tol phosphates. Basal [3H]inositol phosphate accumula-
tion was of the same magnitude in control and CFTR-
transduced cells, and no change was observed following
addition of forskolin and isoproterenol. In both cell
types, mechanical stimulation resulted in hexokinase-
attenuable [3H]inositol phosphate formation. In sum-
mary, our data suggest that ATP release may be trig-
gered by mechanical stimulation of cell surfaces. No
evidence was found supporting a role for CFTR in the
release of ATP.
The wide distribution of cell surface P2 receptors (1, 2) and
the presence in most tissues of ectoenzymes that rapidly de-
grade extracellular nucleotides (3) support the notion that reg-
ulated process(es) for the cellular release of ATP may exist.
Indeed, ATP has been found in an extracellular location in
many tissues (4–10), and ATP secretion from intracellular
granules during platelet activation as well as nerve transmis-
sion are well described events where physiological release of
nucleotides occurs (4). However, in most tissues where signifi-
cant ATP concentrations in the extracellular space have been
detected, the mechanism(s) of ATP release have not been
identified.
In the airways, the volume and composition of the liquid
secretions may be regulated by extracellular nucleotides (11–
14). In cystic fibrosis (CF)1 airway epithelia, the P2Y2 receptor
is linked to a Ca21-dependent chloride channel that provides
an alternative Cl2 secretory pathway to the CF transmem-
brane regulator (CFTR) Cl2 channel (11). This alternative chlo-
ride channel (Cla) has been identified as a potential target for
therapy of CF lung disease. The localization of P2Y2 receptors
on the apical surface of airway epithelia suggests the possibil-
ity that these receptors are regulated endogenously by the
release of ATP onto the lumen.
It has been recently proposed that CFTR itself modulates the
composition of airway surface liquids by acting as a channel for
ATP, regulating Cla pathways via activation of P2Y2 receptors
(15). In CF with defective CFTR, an implication of this hypoth-
esis is that resting levels of ATP would be reduced, resulting in
reduced Cla as well as CFTR activation. The notion that CFTR
mediates the release of ATP evolved from studies showing that
protein kinase A stimulated a single channel (CFTR) current in
CFTR-expressing cells when 100 mM ATP was present in the
intracellular compartment (15, 16). In addition, CFTR was
shown to regulate the activity of a second chloride channel in
excised patches, an activity thought to reflect ATP release and
activation of outwardly rectifying Cl2 channels by P2Y2 recep-
tors (15). However, other studies found either no evidence for
CFTR-mediated ATP conductance (17–19) or that some but not
all CFTR Cl2 channels could be associated with an ATP per-
meability (20). Measurements of ATP released from cells have
also produced results that either support (15, 21) or do not
support (22, 23) a role for CFTR in the regulation of ATP
release. The current debate (24–26) reflects the uncertainty
that prevails on this issue (reviewed in Ref. 27). In this study,
we tested the function of CFTR as a pathway for ATP release
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using both biochemical methods for directly measuring ATP
release in intact cells and an assay utilizing the human P2Y2
receptor as a biological reporter for ATP release within the
relevant cellular biophase (receptor domain).
MATERIALS AND METHODS
Cell Culture—Primary cultures of human nasal epithelial (HNE)
cells and immortalized nasal epithelial cells from either normal or CF
mice (28) were grown as polarized epithelia on 12.5-mm porous
Transwell Col filters (Costar) as reported previously (29). Assays with
HNE cells were carried out 7–10 days after seeding, a time coincident
with the development of the maximal ion transport activity (29). T84
human colonic carcinoma cells, a cell line expressing high levels of
endogenous CFTR (30), were grown as a polarized epithelium onto
cross-linked collagen supports as described previously (30). Control and
CFTR-transduced NIH-3T3 fibroblasts were grown on 12-well plastic
plates as described (31). HP2U-1321N1 cells, a clonal cell line derived
from human astrocytoma cells stably expressing the human P2Y2 re-
ceptor (32), were grown on 12-well plastic plates (inositol phosphate
assay) or on 6-well plates (36Cl2 efflux measurement and Western
blotting) in DMEM-H containing 5% fetal bovine serum and antibiotics
as described previously (9).
Luciferin/Luciferase Assay—HNE cells were preincubated for 1 h in
a Krebs-Ringer solution (2.4 mM K2HPO4, 0.4 mM KH2PO4, 115 mM
NaCl, 1.2 mM MgCl2, 1.2 mM CaCl2, 25 mM NaH2CO3, and 5 mM glucose)
at 37 °C and 5% CO2. The cells were exposed for the indicated times to
the designated drug. The mucosal medium (0.3 ml) was collected, cen-
trifuged to remove potentially detached cells, and boiled for 1 min. A
100-ml sample aliquot was diluted with 200 ml of H2O prior to meas-
urements. The luciferin/luciferase mixture (300 mM luciferin, 5 mg/ml
luciferase, 25 mM HEPES (pH 7.8), 6.25 mM MgCl2, 0.63 mM EDTA, 75
mM dithiothreitol, and 1 mg/ml bovine serum albumin) was added to
samples via an LB953 AutoLumat luminometer (Berthold GmbH, Wild-
bad, Germany), and the sample luminescence was compared with an
ATP standard curve performed for each individual experiment. To
assess intracellular ATP content, cells were lysed with 5% trichloroace-
tic acid followed by ethyl ether extraction and neutralization.
Release of [3H]Adenine-labeled Nucleotides—The cells were labeled
for 3 h with 10 mCi/ml [3H]adenine as described previously (33). Labeled
cells were exposed to the indicated drug without washing away the label
to avoid unnecessary agitation of the cells. The mucosal medium was
collected, and 3H-labeled species were resolved by high pressure liquid
chromatography (HPLC).
Nucleoside Diphosphokinase (NDPK)-catalyzed Formation of
[a-33P]dATP—NDPK catalyzes the phosphorylation of nucleoside
diphosphates utilizing ATP as the g-phosphate donor molecule (34). We
used [a-33P]dADP, obtained as described previously (29), as the accep-
tor molecule to quantitatively determine the formation of [a-33P]dATP
as a function of ATP concentration. HNE cells and nasal epithelial cells
from either wild-type or CF mice were preincubated for 1 h in 0.3 ml of
(mucosal) HEPES (pH 7.4)-buffered DMEM-H (HEPES/DMEM). Incu-
bations were in the presence of 0.5 units/ml NDPK and 10 nM
[a-33P]dADP (0.2 mCi) added to the mucosal bath. 33P-Labeled species
were resolved by HPLC.
Quantification of Nucleotides by HPLC—Nucleotides were separated
by HPLC (Shimadzu) via a strong anion-exchange column (Rainin In-
strument Co. Inc.) with a mobile phase developed from 0.45 M
NH4COOH (pH 4.8) to 0.5 M Na2H2PO4 (pH 2.7) over a 30-min period
(9). Radioactivity was measured on line with a Radiomatic 500TR
analyzer (Packard Instrument Co.). Species were identified and quan-
tified as described previously (9).
Release of 51Cr from HNE Cells—Confluent polarized HNE cells were
incubated for 3 h in HEPES/DMEM containing 10 mCi of [51Cr]Na2CrO3
added to the mucosal bath. The cells were washed (four times) and
preincubated for 1 h in HEPES/DMEM. The mucosal solution (0.5 ml)
was removed at the times indicated, and the radioactivity was quanti-
fied with a Cobra Autogamma counter (Packard Instrument Co.).
Expression of CFTR in HP2U-1321N1 Astrocytoma Cells—Subcon-
fluent HP2U-1321N1 cells grown on 12-well plastic plates were infected
with adenoviral vector (5 3 109 particles/well) containing DNA encod-
ing either the CFTR gene (AdCFTR) or LacZ gene (AdLacZ) as de-
scribed (31). Cells were assayed for CFTR expression 48 h after infec-
tion. For Western blot analysis, CFTR was localized with an antiserum
raised against a carboxyl-terminal peptide of CFTR (35). [36Cl]Chloride
efflux was quantified as described previously (31).
Measurement of [3H]Inositol Phosphates—HP2U-1321N1 cells were
labeled overnight in 0.5 ml of inositol-free DMEM-H containing 4
mCi/ml myo-[3H]inositol. At the time of assay, 10 mM LiCl was added to
the cells for 15 min, followed by a further 15-min incubation in the
presence of the indicated drugs. Incubations were terminated by the
addition of 5% trichloroacetic acid, and the resulting [3H]inositol phos-
phates were separated and quantified by chromatography on Dowex
columns as described previously (9).
Reagents—ATP and dATP were purchased from Pharmacia (Upp-
sala, Sweden). Hexokinase, NDPK, forskolin, and dADP were from
Boehringer Mannheim. Luciferin, luciferase, and isoproterenol were
obtained from Sigma. [3H]Adenine (17 Ci/mmol) and myo-[3H]inositol
(20 Ci/mmol) were from American Radiolabeled Chemicals (St. Louis,
MO). [a-33P]dATP (3000 Ci/mmol), [51Cr]Na2CrO3 (300–500 mCi/mg
cromium), and [36Cl]NaCl (3 mCi/g chloride) were from Amersham
Pharmacia Biotech.
Expression of the Results—Except where stated otherwise, pooled
data are expressed as means 6 S.E. and are representative of at least
three independent experiments performed with duplicate or triplicate
samples. For statistical comparisons, unpaired t test was used, and p ,
0.05 was considered significant.
RESULTS
Release of ATP from HNE Cells—ATP was quantified in the
mucosal medium bathing HNE cells utilizing the luciferin/
luciferase method. Under resting conditions, i.e. the cells were
kept undisturbed for 1 h prior to the assay, accumulation of
ATP was 18.5 6 3.4 pmol/106 cells (3.3 6 0.6 nM in 0.3 ml of
medium; n 5 9). Cell monolayers incubated with forskolin and
isoproterenol (20 mM each, 10 min), a drug combination that is
maximally effective in initiating cyclic AMP-dependent Cl2
secretion via CFTR (33), exhibited a concentration of (mucosal)
ATP of 4.2 6 0.7 nM (25.1 6 4.1 pmol/106 cells; n 5 9), a value
not significantly different from control incubations. In contrast,
perturbing the cell surface by a medium change (data not
shown) or by gently pipetting the mucosal medium up and
down twice resulted in a marked accumulation of mucosal ATP
(49.5 6 8 nM, 297 6 61 pmol/106 cells). Mechanically released
ATP by a medium displacement represented 0.9–1.6% of the
cellular ATP content, and it was unaffected by exposing the
cells to the cyclic AMP mixture (51 6 12 nM, 306 6 79 pmol/106
cells). The possibility that cell lysis occurred during mechanical
stimulation was investigated with 51Cr-loaded HNE cells. No
changes in 51Cr base-line levels were observed during a 10-min
period following a medium displacement (Table I). Moreover,
base-line radioactivity remained unchanged after five repeti-
tive medium displacements (data not shown). Thus, although
we cannot rule out the possibility that a small number of
damaged cells contributed to 51Cr base-line levels, our results
suggest that ATP was released from intact (not damaged) cells.
Consistent with this, we have recently shown that no cell lysis
occurred during mechanically promoted ATP release from
1321N1 cells (36).
Release of [3H]Adenine-labeled Nucleotides—We loaded the
intracellular pool of ATP with [3H]adenine, and the release of
3H-labeled species was quantified by HPLC. Because the rela-
tively large release of [3H]ATP during medium changes (data
not shown and Ref. 9) could mask a potential contribution by
CFTR, a protocol was utilized that avoided cell washes. HPLC
analysis of (mucosal) medium bathing resting [3H]adenine-
labeled HNE cells demonstrated a small peak of [3H]ADP,
barely distinguishable from background levels (Fig. 1A) (non-
incorporated [3H]adenine eluted at 5–8 min). No increase in
[3H]ATP or [3H]ADP accumulation was observed in forskolin/
isoproterenol-stimulated HNE cells (Fig. 1B). Incubation of
cells with ionomycin to induce elevation of intracellular Ca21
resulted in a small accumulation of extracellular [3H]ATP and
greater accumulation of [3H]ADP (Fig. 1C). A marked accumu-
lation of [3H]ATP and [3H]ADP was observed after a medium
displacement (Fig. 1D). This protocol was repeated with T84
cells and with NIH-3T3 cells stably expressing either normal
CFTR or the a-subunit of the interleukin-2 receptor as a control
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(31). In all cases, addition of forskolin/isoproterenol (2–10 min)
promoted no release of [3H]adenine-labeled species, but a large
accumulation of 3H-labeled nucleotides was observed after a
medium displacement irrespective of the presence of CFTR
(data not shown).
ATP-dependent Conversion of [a-33P]dADP to [a-33P]dATP—
The possibility that CFTR mediates the release of ATP from a
nucleotide pool not accessed by [3H]adenine (37) was investi-
gated by trapping released ATP with NDPK and [a-33P]dADP.
The NDPK-catalyzed conversion of [a-33P]dADP to
[a-33P]dATP was measured by HPLC as a function of ATP
concentration (Fig. 2). Moreover, since exogenous NDPK activ-
ity greatly exceeds endogenous ecto-ATPase activity, the assay
resulted in a system that effectively locks the g-phosphate of
ATP onto the [a-33P]dADP molecule upon release. Fig. 3 illus-
trates the conversion of [a-33P]dADP to [a-33P]dATP in the
mucosal HNE cell baths under various conditions. A basal
conversion (16 6 3%) of [a-33P]dADP to [a-33P]dATP was ob-
served with cells that had not been treated with agonists (Fig.
2A). Addition of forskolin and isoproterenol (20 mM each) did
not result in increased conversion (14 6 4%) of [a-33P]dADP to
[a-33P]dATP, indicating that elevation of cellular cyclic AMP
did not promote the release of ATP (Fig. 2B). However, an
;2-fold greater conversion (26 6 3%) of [a-33P]dADP to
[a-33P]dATP was observed following addition of 1 mM ionomy-
cin, consistent with a Ca21-promoted ATP release (Fig. 2C). A
4-fold increased formation (71 6 6%) of [a-33P]dATP occurred
following mechanical stimulation of the cells (Fig. 2D). The
calculated ATP concentrations were 6 6 1, 5 6 1, 17 6 3, and
97 6 11 nM for control cells, cAMP-stimulated cells, ionomycin-
treated cells, and mechanically stimulated cells, respectively.
This protocol was repeated with immortalized nasal epithe-
lial cells derived from either normal or CF mice. The results,
summarized in Fig. 4, showed no differences between normal
and CF cells under basal or forskolin/isoproterenol-stimulated
conditions. The increased [33P]dATP formation observed after
mechanical stimulation was also similar in control and CF
mouse cells. The muscarinic-cholinergic agonist carbachol pro-
moted a small increase in [33P]dATP formation, although this
was not statistically significant.
The P2Y2 Receptor as a Biosensor for ATP—Finally, in an
attempt to assay for CFTR-dependent ATP release in the rel-
evant physiological environment, i.e. the liquid layer associated
with the cell surface, we used the P2Y2 receptor as a biosensor
for ATP to investigate the role of CFTR in the activation of
P2Y2 receptors in intact cells. As such, we took advantage of a
cell line (1321N1 human astrocytoma cells) that is null for
expression of P2 receptors (32). First, we achieved a high ex-
pression level of P2Y2 receptors by retroviral infection of
1321N1 cells with the cDNA encoding the human P2Y2 recep-
tor (32). 1321N1 cells stably expressing the human P2Y2 re-
ceptor (HP2U-1321N1 cells) exhibit a marked ATP-stimulated
formation of inositol phosphates, whereas control cells are un-
responsive (9). Overexpression of the P2Y2 receptor in 1321N1
cells resulted in large receptor reserve, and consequently, ATP
potency in HP2U-1321N1 cells (EC50 5 180 nM (9)) is increased
30-fold relative to ATP potency observed with the P2Y2 recep-
tor natively expressed in airway epithelial cells (38). More
important, significant accumulation of inositol phosphates in
HP2U-1321N1 cells was detectable at concentrations of ATP as
low as 10 nM (see Fig. 6 and Ref. 9). Second, we infected the
HP2U-1321N1 cells with an adenoviral vector containing the
CFTR cDNA (AdCFTR) or with adenoviral vectors encoding the
LacZ gene (AdLacZ) as a control and assayed for the effect of
CFTR expression on the accumulation of inositol phosphates.
FIG. 1. Release of 3H-labeled species from [3H]adenine-labeled
HNE cells. [3H]Adenine-loaded HNE cells were incubated (300 ml of
mucosal bath) for 10 min with vehicle (A), 20 mM isoproterenol and 20
mM forskolin (B), or 1 mM ionomycin (C), or they were subjected to a
gentle medium displacement by withdrawing and placing back twice
150 ml of the mucosal medium (D). The [3H]adenine-labeled species
present in the mucosal medium were analyzed by HPLC as detailed
under “Materials and Methods.”
FIG. 2. ATP-dependent conversion of [a-33P]dADP to
[a-33P]dATP. Incubations were for 10 min in 0.5 ml of DMEM-H
containing 0.5 units/ml NDPK, 10 nM [a-33P]dADP, and the indicated
concentrations of ATP. The formation of [a-33P]dATP was quantified by
HPLC as indicated under “Materials and Methods.” The data are the
means 6 S.E. from four experiments performed in duplicate.
TABLE I
Release of 51Cr from HNE cells
Mechanical stimulation was applied to [51Cr]Na2CrO3-labeled HNE
cells by gently pipetting up and down 0.25 ml of the mucosal medium
twice. Undisturbed and stimulated cells were incubated for the times
indicated, and the radioactivity released into the mucosal medium was
quantified. The results are expressed as the means 6 S.E. from tripli-
cate samples, and they are representative of two independent experi-
ments performed under similar conditions.
Control Mechanical stimulation
cpm cpm
0 min 775 6 52 752 6 30
1 min 806 6 124 850 6 172
5 min 772 6 209 730 6 182
10 min 780 6 234 722 6 75
SDS 17,043 6 3995 19,117 6 2556
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Fig. 5A shows a Western blot for CFTR of lysates from AdLacZ-
or AdCFTR-infected cells. A band (;180 kDa), revealed by an
anti-CFTR antiserum (antiserum 858 (35)), was present in
AdCFTR-infected cells, but not in cells infected with the LacZ
vector. A functional cyclic AMP-activated Cl2 permeability was
demonstrated in AdCFTR-infected HP2U-1321N1 cells, but not
in AdLacZ-infected cells, as indicated by forskolin- and isopro-
terenol-stimulated 36Cl2 efflux (Fig. 5B).
Fig. 6 illustrates the effect of CFTR expression and cyclic
AMP-dependent activation on P2Y2 receptor-promoted accu-
mulation of inositol phosphates in HP2U-1321N1 cells. Basal
accumulation of inositol phosphates was indistinguishable
among control HP2U-1321N1 cells (i.e. cells that were not
infected with adenovirus) and AdLacZ- and AdCFTR-infected
HP2U-1321N1 cells, indicating that the mere expression of
CFTR did not result in basal ATP-mediated activation of P2Y2
receptors. To test the effect of cyclic AMP-activated CFTR,
inositol phosphates were measured following addition of for-
skolin and isoproterenol. No increase in the total formation of
inositol phosphates was observed with any cell type in response
to this maneuver (Fig. 6). As a control for the sensitivity of the
cells used in this assay, the cells were exposed to 10 nM exog-
enous ATP, and similar 3–4-fold increases in inositol phos-
phate accumulation were observed in the three cell types. We
also tested for expression of a Ca21i regulation of ATP release
in astrocytoma cells by addition of ionomycin, which resulted in
a significant accumulation of inositol phosphates in all three
cell types (Fig. 6) that was abolished when hexokinase was
included in the assay (data not shown). We have previously
shown that wild-type as well as HP2U-1321N1 cells release
considerable amounts of ATP into the medium during a me-
dium change (9, 32). Consistent with these previous reports,
displacement of the medium bathing HP2U-1321N1 cells re-
sulted in a marked accumulation of inositol phosphates (Fig. 6)
that was sensitive to hexokinase and that was similar in mag-
nitude to accumulation stimulated by 100–300 nM ATP (data
not shown). No difference in response to this maneuver was
observed between control cells or cells expressing CFTR (Fig.
6). We conclude from these experiments that CFTR has no role
in ATP release, whereas elevation of intracellular calcium
and/or mechanical stimulation of HP2U-1321N1 human astro-
cytoma cells results in the release of ATP by a CFTR-independ-
ent mechanism.
DISCUSSION
This study demonstrates the presence of ATP in the mucosal
surface liquid of nonstimulated airway epithelial cells and that
accumulation of extracellular ATP increases substantially
when cells are subjected to mechanical stimuli. Unlike previous
studies in which CFTR was reported to act as an ATP channel
FIG. 3. Conversion of [a-33P]dADP to [a-33P]dATP in the me-
dium bathing HNE cells. The cells were incubated with vehicle (A),
forskolin and isoproterenol (B), or ionomycin (C), or they were subjected
to a medium displacement (D) as detailed in the legend of Fig. 1.
Incubations were for 10 min in the presence of 0.5 units/ml NDPK and
10 nM [a-33P]dADP, and the resulting a-33P-labeled species were quan-
tified by HPLC as described under “Materials and Methods.” All addi-
tions were to the mucosal medium. The results are representative of
three experiments performed in duplicate.
FIG. 4. Conversion of [a-33P]dADP to [a-33P]dATP in the me-
dium bathing mouse nasal epithelial cells. Cells from wild-type
(WT; white bars) or CF (black bars) mice were incubated with vehicle,
20 mM forskolin and 20 mM isoproterenol (forsk/isoprot), or 1 mM car-
bachol (carb), or they were subjected to a medium displacement (medi-
um displac). Incubations were for 10 min in the presence of 0.5 units/ml
NDPK and 10 nM [a-33P]dADP, and the resulting a-33P-labeled species
were quantified by HPLC as descried under “Materials and Methods.”
All additions were to the mucosal medium. The results are expressed as
the percent conversion of [a-33P]dADP to [a-33P]dATP, and the data
represent the means 6 S.E. from three experiments performed in du-
plicate. *, p , 0.05.
FIG. 5. Expression of CFTR in HP2U-1321N1 cells. Subconfluent
HP2U-1321N1 cells grown on 12-well (A) or 6-well (B) plastic plates
were infected with adenovirus harboring the CFTR (AdCFTR) or LacZ
(AdLacZ) plasmid (31). A, AdLacZ-infected cells, AdCFTR-infected cells,
and (control) T84 cells were lysed with urea lysis buffer, and proteins
(50 mg/lane) were separated by SDS-polyacrylamide gel electrophoresis
and subsequently transferred to a nitrocellulose membrane. CFTR was
localized with antiserum 858 (35). B, shown is released 36Cl from
36Cl-loaded cells. Forskolin and isoproterenol (20 mM each) were in-
cluded following collection of the 3-min sample. The results are ex-
pressed as percent of the initial intracellular radioactivity and are
representative of two independent experiments performed in triplicate
that differed ,10% from the mean. Error bars were omitted for clarity.
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(15, 16, 21), we found no evidence involving CFTR in the
release of ATP from intact epithelial and non-epithelial cells.
The cause of this discrepancy may reside, at least in part, in the
methodological approaches.
Previously, studies implicating CFTR as an ATP channel
have employed permeabilized cells, membrane patches, and/or
repetitive changes of cell media and in general have subjected
the cells to stresses not consistent with physiological condi-
tions. We have used both classical methods for extracellular
detection of ATP, e.g. the luciferase assay, and HPLC separa-
tion of 3H-labeled nucleotides released from [3H]adenine-pre-
loaded cells as well as newly developed approaches for trapping
ATP with NDPK and have adopted conditions in which sam-
pling for ATP release was carefully controlled. Although we
were able to detect ATP accumulation in the liquids bathing
the surface of resting normal HNE cells, we observed no differ-
ences after incubating the cells with agents that promoted
elevation of intracellular cyclic AMP. Moreover, no differences
were found in extracellular ATP accumulation with nasal epi-
thelial cells from normal or CF mice under basal conditions or
as a function of cyclic AMP pathway stimulation. We have
shown here that a marked release of ATP occurred after me-
chanical stimulation of airway epithelial cell surfaces by a
medium displacement. However, mechanically stimulated re-
lease of ATP was of the same magnitude in normal or CF
airway epithelial cells as well as in control or CFTR-expressing
non-epithelial cells. A CFTR-independent mechanically stimu-
lated ATP release was also recently reported with colonic and
human airway epithelial cell lines (23).
To directly test the potential regulation of P2Y2 receptors by
CFTR, we have used a functional assay in which the P2Y2
receptor acted as a biosensor for releasable ATP. We were able
to couple the advantage of the high expression level of recom-
binant P2Y2 receptors attainable by retroviral infection of
1321N1 cells with adenovirus-mediated expression of CFTR in
these cells to test the effect of CFTR activation on P2Y2 recep-
tor-promoted inositol phosphate formation. Our hypothesis was
that local accumulation of CFTR-releasable ATP in the un-
stirred and consequently difficult to sample liquid layer on the
cell surface would be detected by coexpression of these two
recombinant proteins on the surface of 1321N1 cells. Consist-
ent with our previous reports showing mechanically promoted
release of ATP from 1321N1 cells (9, 36), a sustained accumu-
lation of inositol phosphates was observed following a medium
displacement (Fig. 6). More important, inositol phosphate ac-
cumulation in 1321N1 cells was of the same magnitude regard-
less of CFTR expression, indicating that CFTR was not in-
volved in mechanically induced ATP release. Although HP2U-
1321N1 cells were sensitive to a 10 nM concentration of
exogenously added ATP, no effect on inositol phosphates was
observed following addition of forskolin and isoproterenol to
CFTR-transduced HP2U-1321N1 cells as compared with con-
trol cells. Thus, activation of CFTR in 1321N1 cells did not
result in accumulation of extracellular ATP in concentrations
high enough to promote P2Y2 receptor activation. In summary,
by functionally expressing both CFTR and P2Y2 receptors in a
null cell line, we were able to directly test the hypothesis that
CFTR regulates the activity of P2Y2 receptors. We have found
no evidence to support this hypothesis.
The presence of P2Y2 receptors in the airway epithelia (32,
38) and their coupling to a Cl2 secretory pathway on the
mucosal surface of HNE cells (11) suggest that extracellular
accumulation of nucleotides might be important for the regu-
lation of ion permeabilities. The recent identification of an
ectonucleotidase activity on HNE cells (29) suggests one mech-
anism for regulating extracellular accumulation of nucleotides.
Our present study indicates that ;20 pmol of ATP/106 cells
accumulate at steady state on the mucosal surface of resting
normal HNE cells. This closely resembles the ATP concentra-
tion observed in the lumen of normal human airways in vivo
(39). Furthermore, ATP transiently accumulates following me-
chanical stimulation of cells in concentrations capable of acti-
vating P2Y2 receptors. Previously, mechanically induced non-
lytic release of ATP had been described in a variety of tissues.
For example, changes in blood fluxes were shown to cause the
release of ATP from endothelial cells (10, 40); shear forces
promoted ATP release from mouse fibroblasts (6); and ATP
release secondary to mechanical stimulation was also described
with rat basophilic cells (7), 1321N1 human astrocytoma cells
(9, 36), and rat hepatocytes (8). Stretch-promoted ATP release
was reported with rabbit urinary bladder epithelial cells (41)
and human lung adenocarcinoma Calu-3 cells (40), and ATP
release triggered by bath turbulence was observed with T84
cells and with immortalized human tracheal epithelial cell
lines (23, 26). Our current study extends these observations to
primary human airway epithelial cells. It is not clear whether
mechanical stimulation of airway epithelial cells and release
across the epithelial surface occurs in vivo and what its func-
tional significance might be. Mechanical forces applied on the
airways by air fluxes may represent a primary mechanism for
autocrine and paracrine regulation of electrolyte homeostasis
in airway epithelia.
In conclusion, the techniques used in this study for detecting
extracellular ATP are thought to closely approximate physio-
logical conditions, creating a system in which pertinent and
reliable information is generated. We found that ATP is re-
leased from each of the studied cell types in response to me-
chanical stimulation and/or secondary to elevation of intracel-
lular calcium levels. No evidence was found indicating that
CFTR was involved in ATP release in airway epithelia from two
species. This study suggests that CFTR itself does not directly
effect ATP or regulate other possible ATP release pathways in
the cells we have studied, but our data do not rule out possible
CFTR-dependent regulation of ATP release pathways in other
cell types. The occurrence of ATP release independent of acti-
FIG. 6. Effect of CFTR expression on P2Y2 receptor-mediated
formation of [3H]inositol phosphates. [3H]Inositol-labeled HP2U-
1321N1 cells and cells infected with AdLacZ or AdCFTR were incubated
for 15 min under the indicated conditions. Forskolin and isoproterenol
(cAMP) were added at 20 mM final concentrations, ATP at 10 nM, and
ionomycin (ionom) at 1 mM. medium displac indicates withdrawing and
gently replacing the medium twice. The results represent the means 6
S.E. from four experiments performed in triplicate. WT, wild-type. *,
p , 0.05.
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vation of CFTR raises new possibilities for treatment of CF. For
potential therapeutic targeting, it may important to identify, at
the molecular level, the mechanism involved in nucleotide re-
lease from airway epithelia.
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